Evidence map›Paper›PMID 36962566›Full record

ArticlePLOS global public health2022

Prevalence of SARS-CoV-2 infection in Baja California, Mexico: Findings from a community-based survey in February 2021 in the Mexico-United States border.

Oscar E Zazueta, Richard S Garfein, J Oggun Cano-Torres, César A Méndez-Lizárraga, Timothy C Rodwell, Raquel Muñiz-Salazar, Diego F Ovalle-Marroquín, Neiba G Yee, Idanya Rubí Serafín-Higuera, Susana González-Reyes and 6 more

Open access · goldFull text read
In one paragraph

Article in PLOS global public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Oscar E ZazuetaDepartment of Epidemiology, Secretariat of Health of Baja California, Mexicali, Baja California, Mexico.ORCID https://orcid.org/0000-0001-5374-3906
Richard S GarfeinHerbert Wertheim School of Public Health, University of California San Diego, San Diego, California, United States of America.ORCID https://orcid.org/0000-0003-3663-7153
J Oggun Cano-TorresDepartment of Epidemiology, Secretariat of Health of Baja California, Mexicali, Baja California, Mexico.ORCID https://orcid.org/0000-0002-3341-2023
César A Méndez-LizárragaDepartment of Epidemiology, Secretariat of Health of Baja California, Mexicali, Baja California, Mexico.ORCID https://orcid.org/0000-0001-5022-5089
Timothy C RodwellDepartment of Medicine, University of California San Diego (UCSD), San Diego, California, United States of America.
Raquel Muñiz-SalazarDepartment of Medicine, Universidad Autónoma de Baja California (UABC), Mexicali, Baja California, Mexico.ORCID https://orcid.org/0000-0001-5528-7772
Diego F Ovalle-MarroquínDepartment of Epidemiology, Secretariat of Health of Baja California, Mexicali, Baja California, Mexico.ORCID https://orcid.org/0000-0003-2159-5122
Neiba G YeeDepartment of Epidemiology, Secretariat of Health of Baja California, Mexicali, Baja California, Mexico.ORCID https://orcid.org/0000-0003-0681-5182
Idanya Rubí Serafín-HigueraDepartment of Medicine, Universidad Autónoma de Baja California (UABC), Mexicali, Baja California, Mexico.ORCID https://orcid.org/0000-0002-8974-1766
Susana González-ReyesDepartment of Medicine, Universidad Autónoma de Baja California (UABC), Mexicali, Baja California, Mexico.ORCID https://orcid.org/0000-0003-2260-8415
Jesus Rene Machado-ContrerasDepartment of Medicine, Universidad Autónoma de Baja California (UABC), Mexicali, Baja California, Mexico.ORCID https://orcid.org/0000-0001-5165-9348
Lucy E HortonDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Steffanie A StrathdeeDepartment of Medicine, University of California San Diego (UCSD), San Diego, California, United States of America.ORCID https://orcid.org/0000-0002-7724-691X
Ruth RodríguezDepartment of Population Studies, El Colegio de la Frontera Norte (El Colef), Tijuana, Baja California, Mexico.
Linda HillDepartment of Medicine, University of California San Diego (UCSD), San Diego, California, United States of America.
Ietza Bojórquez-ChapelaDepartment of Population Studies, El Colegio de la Frontera Norte (El Colef), Tijuana, Baja California, Mexico.ORCID https://orcid.org/0000-0003-1723-7269
University of California San Diego · USUniversidad Autónoma de Baja California · MXEl Colegio de la Frontera Norte · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Between March 2020 and February 2021, the state of Baja California, Mexico, which borders the United States, registered 46,118 confirmed cases of COVID-19 with a mortality rate of 238.2 deaths per 100,000 residents. Given limited access to testing, the population prevalence of SARS-CoV-2 infection is unknown. The objective of this study is to estimate the seroprevalence and real time polymerase chain reaction (RT-PCR) prevalence of SARS-CoV-2 infection in the three most populous cities of Baja California prior to scale-up of a national COVID-19 vaccination campaign. Probabilistic three-stage clustered sampling was used to conduct a population-based household survey of residents five years and older in the three cities. RT-PCR testing was performed on nasopharyngeal swabs and SARS-CoV-2 seropositivity was determined by IgG antibody testing using fingerstick blood samples. An interviewer-administered questionnaire assessed participants' knowledge, attitudes, and preventive practices regarding COVID-19. In total, 1,126 individuals (unweighted sample) were surveyed across the three cities. Overall prevalence of SARS-CoV-2 infection by RT-PCR was 7.8% (95% CI 5.5-11.0) and IgG seroprevalence was 21.1% (95% CI 17.4-25.2). There was no association between border crossing in the past 6 months and SARS-CoV-2 prevalence (unadjusted OR 0.40, 95%CI 0.12-1.30). While face mask use and frequent hand washing were common among participants, quarantine or social isolation at home to prevent infection was not. Regarding vaccination willingness, 30.4% (95% CI 24.4-3 7.1) of participants said they were very unlikely to get vaccinated. Given the high prevalence of active SARS-CoV-2 infection in Baja California at the end of the first year of the pandemic, combined with its low seroprevalence and the considerable proportion of vaccine hesitancy, this important area along the Mexico-United States border faces major challenges in terms of health literacy and vaccine uptake, which need to be further explored, along with its implications for border restrictions in future epidemics.

Identifiers

PMID36962566
PMCPMC10021449
OpenAlexW4289524809

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read126
identifiers read9
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.